Anti-cancer effects of the HuR inhibitor, MS-444, in malignant glioma cells
Author:
Affiliation:
1. Departments of Neurology, University of Alabama, Birmingham, AL
2. Cell, Developmental, and Integrative Biology, University of Alabama, Birmingham, AL
3. Birmingham Veterans Affairs Medical Center, Birmingham, AL
Funder
Department of Veterans Affairs
Publisher
Informa UK Limited
Subject
Cancer Research,Pharmacology,Oncology,Molecular Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/15384047.2019.1591673
Reference57 articles.
1. Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial
2. Recurrent Glioblastoma Treated with Recombinant Poliovirus
3. Cancer stem cells in glioblastoma
4. Glioblastoma: new therapeutic strategies to address cellular and genomic complexity
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. RNA-binding protein HuR reprograms immune T cells and promotes oral squamous cell carcinoma;Oral Oncology Reports;2024-06
2. Inflammation as a driver of hematological malignancies;Frontiers in Oncology;2024-03-20
3. Human antigen R: Exploring its inflammatory response impact and significance in cardiometabolic disorders;Journal of Cellular Physiology;2024-03
4. A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradation;Nature Communications;2023-11-04
5. Targeting the RNA-Binding Protein HuR in Cancer;Cancer Research;2023-09-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3